HIV-1 Infection Among Intravenous Drug Users in Vienna 1986–1991

  • N. Loimer
  • O. Presslich
  • E. Werner
  • G. Pakesch
  • E. Hollerer
  • V. Pfersmann
  • H. Vedovelli


Current research and clinical experience with AIDS in the population of intravenous drug users demonstrates that members of this group have multiple opportunities for exposure to HIV (Friedland & Klein 1987). Following the introduction of HIV into a community of intravenous drug users (IVDUs), it may infect over 50% of individuals within three to four years (Des Jarlais et al. 1988), the potential for a major heterosexual epidemic remains a subject of speculation (Johnson, 1988). The time until AIDS diagnosis after infection is estimated with a mean of 9.8 years (Bacchetti & Moss 1990). The second wave of HIV epidemic in Europe has already formed the injecting drug users into the major component of this epidemic. There has been a dramatic increase in the incidence of AIDS among IVDUs in Europe (Ferroni et al.1985; Fuchs et al. 1985; Ancelle-Park et al. 1987; Robertson et al. 1986, Harms et al. 1987; France et al. 1988; Loimer et al. 1990a) and in the United States (Chamberland et al. 1984; Des Jarlais et al. 1987; Drucker 1987; Allen et al. 1988; Hahn et al. 1989). In Europe higher though less than exponential rates of growth are observed among intravenous drug users. Projections of total cumulated cases to the end of 1991 lie in the range of 23,000 – 33,000 cases among this group (Downs et al. 1990).


Human Immunodeficiency Virus Drug User Inject Drug User Methadone Maintenance Treatment Methadone Maintenance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. ALLEN JR, CURRAN JW (1988) Prevention of AIDS and HIV infection: needs and priorities for epidemiologic research. Am J Public Health 78: 381–386.PubMedCrossRefGoogle Scholar
  2. ANCELLE-PARK R, BRUNET JP, DOWNS AM (1987) AIDS and drug addicts in Europe. Lancet 12: 626–627.CrossRefGoogle Scholar
  3. BACCHETTI P, MOSS AR (1990) Incubation period of AIDS in San Francisco. Nature 338: 251–253.CrossRefGoogle Scholar
  4. BALL JC, LANGE WR, MYERS CP, FRIEDMAN SR (1988) Reducing the risk of AIDS through methadone maintenance treatment. J Health Social Behav 29: 214–226.CrossRefGoogle Scholar
  5. BATTJES RJ, PICKENS RW, AMSEL Z, BROWN LS. (1990) Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J Infect Dis 162 (5): 1007–1011.PubMedCrossRefGoogle Scholar
  6. BROWN LS, MURPHY DL, PRIMM BJ (1987) Sex partners of intravenous drug abusers: implications for the next spread of the AIDS epidemic, Paper presented at the 49th Annual Scientific Meeting of the Problems of Drug Dependence.Google Scholar
  7. BSCHOR F (1986) Drug replacement treatment of drug addicts. Deut Med Woschr 111: 1658–1659.Google Scholar
  8. CHAISSON RE, OSMOND D, MOSS AR, FELDMAN HW, BERNACKI, P (1987) HIV, Bleach, and needle sharing. Lancet 1430.Google Scholar
  9. CHAMBERLAND ME, CASTRO KG, HAVERKOS HW, MILLER BI (1984) Acquired immmunodeficiency syndrome in the United States:an analysis of cases outside high-incidence groups. An Intern Medicine 101: 617–623.Google Scholar
  10. COOPER JR (1989) Methadone treatment and acquired immunodefiency syndrome. JAMA 262: 1664–1668.PubMedCrossRefGoogle Scholar
  11. DES JARLAIS DC, FRIEDMAN SR, STONEBURNER RL (1988) HIV infection and intravenous drug abuse: Critical issues in transmission dynamics, infection outcomes and prevention. Rev Inf Dis 10: 151–158.CrossRefGoogle Scholar
  12. DES JARLAIS DC, WISH E, FRIEDMAN SR, STONEBURNER R, YANCOWITZ SR, MILDVAN D, EL-SADR W, BARDY E, CUARDRADO M (1987) Intravenous drug use and the heterosexual transmission of the Humane Immunodefiency Virus: current trends in New York City, NY State J Med 238–286.Google Scholar
  13. DRUCKER E (1986) AIDS and addiction in New York City. Am J Drug Alcohol Abuse 12, 1&2:165–181.Google Scholar
  14. DOLE V (1989) Methadone treatment and the aquired immunodefiency syndrome epidemic. JAMA 262: 1681–1682.PubMedCrossRefGoogle Scholar
  15. DONOGHOE MC, STIMSON GV, DOLAN KA (1989) Sexual behavior of injecting drug users and associated risks of HIV infection for non injecting sexual partners. AIDS CARE 1: 51–58.PubMedCrossRefGoogle Scholar
  16. DOWNS AM, ANCELLE-PARK RA, BRUNET JB (1990) Surveillance of AIDS in the European Community: recent trends and predictions to 1991. AIDS 4, 11: 1117–1124.PubMedCrossRefGoogle Scholar
  17. FERRONI P, GEROLDI D, GALLI C, ZANETTI AR, CARGNEL A (1985) HTLVIII antibody among Italian drug addicts. Lancet 52.Google Scholar
  18. FRANCE AJ, SKIDMORE CA, ROBERTSON JR, BRETTLE RP, ROBERTS JJJ, BURNS SM, FOSTER CA, INGLIS JM, GALLOWAY WBF, DAVIDSON SJ (1988) Heterosexual spread of immunodeficiency virus in Edinburgh. Brit Med J 296: 526–529.CrossRefGoogle Scholar
  19. FRIEDLAND GH, KLEIN RS (1987) Transmission of human immunodeficiency virus. N England J Med 317: 1125–1135.CrossRefGoogle Scholar
  20. FUCHS D, BLECHA HG, DEINHARDT F, DIERICH P, GOEBEL FD, HENGSTER P, HINTERHUBER H, SCHONITZER D, TRAILL K, WACHTER H (1985) High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austian Tyrol. Lancet 1506.Google Scholar
  21. GHODSE AH, TREGANZA G, LI M (1986) Effect of AIDS on sharing of eqipment among drug abusers. Brit Med J. 295: 698–699.CrossRefGoogle Scholar
  22. HAHN RA, ONORATO IM, JONES TS, DOUGHERTY J (1989) Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 261: 2677–2684.PubMedCrossRefGoogle Scholar
  23. HART GM, CARVEL ALM, WOODWARD N, JOHNSON AM, Williams P, Parry JV (1989) Evaluation of needle exchange in central London: behavior change and anti-HIV status over one year. AIDS. 3: 261–265.PubMedCrossRefGoogle Scholar
  24. HARMS G, LAUKAMM-JOSTEN U, BIENZLE U, GUGGENMOOSHOLZMANN I (1987) Risk factors for 111V infection in German i.v. drug abusers. Klin Wochenschr 65: 376–379.PubMedCrossRefGoogle Scholar
  25. JOHNSON AM (1988) Heterosexual transmission of humane immunodeficiency virus. Brit Med J. 296: 1017–1020.CrossRefGoogle Scholar
  26. LOIMER N, PRESSLICH O, HOLLERER E, PAKESCH G, PFERSMANN V, WERNER E (1990a) Monitoring HIV-1 infection prevalence among intravenous drug users in Vienna 1986–1990. AIDS CARE. 2, 3: 281–286.PubMedCrossRefGoogle Scholar
  27. LOIMER N, PRESSLICH O, HOLLERER E, WERNER E, PAKESCH G, PFERSMANN V, SCHMID-SIEGEL B (1990b) Prävalenz von HIV-Infektion bei intravenös Drogenabhängigen 1986 bis 1989 in Wien. Wi Kli Woschrift 102, 4:106–110.Google Scholar
  28. LOIMER N, PRESSLICH O, HOLLERER E, PAKESCH G, PFERSMANN V, WERNER E (1990c) Sexual behavior and prevalence of HIV-1 infection among intravenous drug users in Vienna 1986–1989. J Sex Educat Therap 16, 4: 242–250.Google Scholar
  29. LOIMER N, WERNER E, PRESSLICH O (1991) Sharing spoons: A risk factor for 111V-1 infection in Vienna. Brit J Addict 86: 775–778.CrossRefGoogle Scholar
  30. MARMOR M, DES JARLAIS DC, COHEN H, FRIEDMAN SR, BEATRICE ST, DUBIN N, EL-SADR W, MILDVAN D, YANCOVITS S, MATHUR U, HOLZMAN R. (1987) Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 39–44.Google Scholar
  31. MOSS AR (1987) AIDS and IV drug use the real heterosexual epidemic, Brit Med J 294: 389–390.CrossRefGoogle Scholar
  32. NOVICK DM, JOSEPH H, CROXSON TS, SALSITZ EA, WANG G, RICHMAN BL, PORETSKY L, KEEFE JB, WHIMBEY E (1990) Absence of antibody to human immunodefiency virus in long term, socially rehabilitated methadone maintenance patients. Arch Intern Med 150: 97–99.PubMedCrossRefGoogle Scholar
  33. PETERSON JL, MARIN G (1988) Issues in the prevention of AIDS among black and hispanic men. Am Psychol 43: 11, 871–877.PubMedCrossRefGoogle Scholar
  34. ROBERTSON JR, BUCKNALL ABV, WIGGINS P (1986) Regional variations in HIV antibody seropositivity in british intravenous drug users. Lancet 4435–1436.Google Scholar
  35. ROBERTSON JR, SKIDMORE CA, ROBERTS JJK (1988) HIV infection in intravenous drug users: a follow-up study indicating changes in risk-taking behavior. Brit J Addict 83: 387–391.CrossRefGoogle Scholar
  36. SCHOENBAUM EE, HARTEL D, SELWYN PA, KLEIN RS, DAVENNY K, ROGERS M, FEINER C, FRIEDLAND G. (1989) Risk factors for human immunodeficiency virus infection in intravenous drug users. N England J Med 321: 874–879.CrossRefGoogle Scholar
  37. SELWYN PA, FEINGOLG AR, IEZZA A, SATYADEO M, COLLY J, TORRES R, SHAW JF. (1989) Primary care for patients with HIV infection in a methadone maintenance program. Ann Intern Med 111, 9: 761–763.PubMedGoogle Scholar
  38. SIEGEL K, GIBSON WC. (1988) Barrriers to the modification of sexual behavior among heterosexuals at risk for acquired immunodefiency syndrome. NY State J Medi 2: 66–70.Google Scholar
  39. SORENSEN JL, BAKTI SL, GOOD P, WILKINSON K (1989) Methadone maintenance program for AIDS-affected opiate addicts. J Substance Abuse Treatment 6: 87–94.CrossRefGoogle Scholar
  40. STIMSON GV, ALLDRITT L, DOLAN K, DONOGHOE M, LART RA (1988) Injecting equipment exchange schemes: Final report. London, Goldsmiths College.Google Scholar
  41. WODAK A, DOLAN K, IMRIE AA, GOLD J, WOLK J, WHYTE BM, COOPER D (1987) Antibodies to the human immunodefiency virus in needles and syringes used by intravenous drug abusers. Med J Australia 147: 275–276.PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • N. Loimer
    • 1
  • O. Presslich
    • 1
  • E. Werner
    • 1
  • G. Pakesch
    • 1
  • E. Hollerer
    • 1
  • V. Pfersmann
    • 1
  • H. Vedovelli
    • 1
  1. 1.Department of PsychiatryUniversity of ViennaWienAustria

Personalised recommendations